Neuroinflammation Is a Key Player in Parkinson’s Disease and a Prime Target for Therapy

Journal of Neural Transmission - Germany
doi 10.1007/s00702-010-0428-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Argonaute3 Is a Key Player in miRNA-mediated Target Cleavage and Translational Repression inChlamydomonas

Plant Journal
Plant ScienceGeneticsCell Biology
2016English

Α-Synuclein: A Therapeutic Target for Parkinson’s Disease?

Pharmacological Research
Pharmacology
2008English

LRRK2 and Neuroinflammation: Partners in Crime in Parkinson’s Disease?

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2014English

A Prescription for Physical Therapy and Exercise in Parkinson’s Disease

Advances in Parkinson's Disease
2013English

Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease

Cell
BiochemistryGeneticsMolecular Biology
2016English

Drug Development for Alzheimer’s Disease: Microglia Induced Neuroinflammation as a Target?

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Breathing New Life Into an Old Target: Pulmonary Disease Drugs for Parkinson’s Disease Therapy

Genome Medicine
Molecular MedicineGeneticsMolecular Biology
2017English

Cognitive Behavioral Therapy for Insomnia in Parkinson’s Disease: A Case Series

npj Parkinson's Disease
2017English

Targeted Therapy in Oncology: A Key Player in the Move Towards Personalized Medicine

Journal of Developing Drugs
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy